Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal Study to Evaluate the Safety and Efficacy of Cryopreserved Bilayered Cellular Matrix (OrCel) for the Treatment of Venous Ulcers

NCT00270946 is registered in ClinicalTrials.gov with Ortec International as lead sponsor.

NCT NCT00270946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00270946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal Study to Evaluate the Safety and Efficacy of Cryopreserved Bilayered Cellular Matrix (OrCel) for the Treatment of Venous Ulcers
Lead sponsor
Ortec International
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2002
Completion date
December 31, 2003
Enrollment
130
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

venous leg ulcer, venous stasis ulcer